Emergency Use Listing
-
{
- All
- News
-
What Covaxin-Maker Bharat Biotech Said After WHO Approved India-Made Jab
The World Health organisation's approval of Covaxin will expedite global access and availability of the first India-made vaccine against coronavirus worldwide, its manufacturer Bharat Biotech said in a statement.
-
"Takes Longer Sometimes": Top WHO Official As Covaxin Decision Awaited
As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said the process of thoroughly evaluating a vaccine for use and recommending it sometimes takes a longer time.
-
Decision On Covaxin Clearance Next Week, Says WHO
Covaxin, India's indigenously developed coronavirus vaccine, may be cleared by the World Health Organisation as early as next week when the UN agency and an independent group of experts meet.
-
Bharat Biotech Dossier Under Review For Covaxin Emergency Use Listing: WHO
Officials of the World Health Organisation (WHO) had a meeting with the Bharat Biotech and its dossier for Emergency Use Listing of Covaxin is under review by technical experts, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said.
-
Inching Toward Emergency Use Listing By WHO For Covaxin: Bharat Biotech
Emergency Use Listing of Bharat Biotech's Covaxin by WHO is not a long drawn process as a majority of the vaccine makers' facilities have been audited by the global health body, Suchitra Ella, joint managing director of Bharat Biotech, said today.
-
Explained: For Covaxin's Global Emergency Listing, Key Meet With WHO
Bharat Biotech and the World Health Organization held a 'pre-submission' meeting on Wednesday for international emergency use listing (EUL) of Covaxin, the Hyderabad-based company's COVID-19 vaccine
-
What Covaxin-Maker Bharat Biotech Said After WHO Approved India-Made Jab
The World Health organisation's approval of Covaxin will expedite global access and availability of the first India-made vaccine against coronavirus worldwide, its manufacturer Bharat Biotech said in a statement.
-
"Takes Longer Sometimes": Top WHO Official As Covaxin Decision Awaited
As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said the process of thoroughly evaluating a vaccine for use and recommending it sometimes takes a longer time.
-
Decision On Covaxin Clearance Next Week, Says WHO
Covaxin, India's indigenously developed coronavirus vaccine, may be cleared by the World Health Organisation as early as next week when the UN agency and an independent group of experts meet.
-
Bharat Biotech Dossier Under Review For Covaxin Emergency Use Listing: WHO
Officials of the World Health Organisation (WHO) had a meeting with the Bharat Biotech and its dossier for Emergency Use Listing of Covaxin is under review by technical experts, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said.
-
Inching Toward Emergency Use Listing By WHO For Covaxin: Bharat Biotech
Emergency Use Listing of Bharat Biotech's Covaxin by WHO is not a long drawn process as a majority of the vaccine makers' facilities have been audited by the global health body, Suchitra Ella, joint managing director of Bharat Biotech, said today.
-
Explained: For Covaxin's Global Emergency Listing, Key Meet With WHO
Bharat Biotech and the World Health Organization held a 'pre-submission' meeting on Wednesday for international emergency use listing (EUL) of Covaxin, the Hyderabad-based company's COVID-19 vaccine
